PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RPRX vs. VOO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between RPRX and VOO is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

RPRX vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Royalty Pharma plc (RPRX) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
3.23%
6.64%
RPRX
VOO

Key characteristics

Sharpe Ratio

RPRX:

-0.10

VOO:

2.18

Sortino Ratio

RPRX:

0.01

VOO:

2.90

Omega Ratio

RPRX:

1.00

VOO:

1.40

Calmar Ratio

RPRX:

-0.04

VOO:

3.26

Martin Ratio

RPRX:

-0.20

VOO:

14.21

Ulcer Index

RPRX:

10.98%

VOO:

1.94%

Daily Std Dev

RPRX:

21.69%

VOO:

12.66%

Max Drawdown

RPRX:

-49.68%

VOO:

-33.99%

Current Drawdown

RPRX:

-46.04%

VOO:

-2.81%

Returns By Period

In the year-to-date period, RPRX achieves a 2.08% return, which is significantly higher than VOO's 0.48% return.


RPRX

YTD

2.08%

1M

0.50%

6M

3.23%

1Y

-3.97%

5Y*

N/A

10Y*

N/A

VOO

YTD

0.48%

1M

-2.81%

6M

6.64%

1Y

25.77%

5Y*

14.33%

10Y*

13.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RPRX vs. VOO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RPRX
The Risk-Adjusted Performance Rank of RPRX is 3939
Overall Rank
The Sharpe Ratio Rank of RPRX is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of RPRX is 3333
Sortino Ratio Rank
The Omega Ratio Rank of RPRX is 3333
Omega Ratio Rank
The Calmar Ratio Rank of RPRX is 4545
Calmar Ratio Rank
The Martin Ratio Rank of RPRX is 4343
Martin Ratio Rank

VOO
The Risk-Adjusted Performance Rank of VOO is 8383
Overall Rank
The Sharpe Ratio Rank of VOO is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of VOO is 8181
Sortino Ratio Rank
The Omega Ratio Rank of VOO is 8383
Omega Ratio Rank
The Calmar Ratio Rank of VOO is 8383
Calmar Ratio Rank
The Martin Ratio Rank of VOO is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RPRX vs. VOO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Royalty Pharma plc (RPRX) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RPRX, currently valued at -0.10, compared to the broader market-4.00-2.000.002.00-0.102.18
The chart of Sortino ratio for RPRX, currently valued at 0.01, compared to the broader market-4.00-2.000.002.004.000.012.90
The chart of Omega ratio for RPRX, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.40
The chart of Calmar ratio for RPRX, currently valued at -0.04, compared to the broader market0.002.004.006.00-0.043.26
The chart of Martin ratio for RPRX, currently valued at -0.20, compared to the broader market-10.000.0010.0020.00-0.2014.21
RPRX
VOO

The current RPRX Sharpe Ratio is -0.10, which is lower than the VOO Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of RPRX and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.10
2.18
RPRX
VOO

Dividends

RPRX vs. VOO - Dividend Comparison

RPRX's dividend yield for the trailing twelve months is around 3.23%, more than VOO's 1.24% yield.


TTM20242023202220212020201920182017201620152014
RPRX
Royalty Pharma plc
3.23%3.29%2.85%1.92%1.71%0.60%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.24%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%1.85%

Drawdowns

RPRX vs. VOO - Drawdown Comparison

The maximum RPRX drawdown since its inception was -49.68%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for RPRX and VOO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-46.04%
-2.81%
RPRX
VOO

Volatility

RPRX vs. VOO - Volatility Comparison

Royalty Pharma plc (RPRX) has a higher volatility of 5.79% compared to Vanguard S&P 500 ETF (VOO) at 4.44%. This indicates that RPRX's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%AugustSeptemberOctoberNovemberDecember2025
5.79%
4.44%
RPRX
VOO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab